Travel and Flight Restriction
31 Dec 2021
| Total Cases | 94,113 |
| New Cases |
67
|
| New Cases (per 1 million citizens) | 129.82 |
| Transmission Rate | n/a |
| COVID-19 Hazard & Exposure | 4.7 |
| Socio-Economic Vulnerability | 0.7 |
| Health Conditions | 0.1 |
| Access to Health Care | 1 |
| Infrastructure | 1 |
| Lack of Coping Capacity (Hazard-Independent) | 2.6 |
| Lack of Coping Capacity | 3 |
| COVID-19 Lack of Coping Capacity | 3.3 |
| COVID-19 Risk | 4.1 |
| COVID-19 Risk Class | Medium |
| Rank | 94 |
| COVID-19 Total Vaccination | 1,293,258 |
| COVID-19 Daily Vaccination | 998 |
| COVID-19 Vacc. (per 100 citizens) | 250.58 |
| COVID-19 Daily Vacc. (per 1 million citizens) | 1,934 |
| Date | Vaccine | Total Vaccinated |
|---|---|---|
| 13 May 2022 | Pfizer/BioNTech | 710,633 |
| 13 May 2022 | Moderna | 239,403 |
| 13 May 2022 | Oxford/AstraZeneca | 227,825 |
| 13 May 2022 | Johnson&Johnson | 32,329 |
| Air Transport, Passengers Carried | 6 |
| Point of Entry | 4 |
| Access to Cities | 0.1 |
| Mobile Cellular Subscriptions (per 100 people) | 3.1 |
| Internet Users | 2.3 |
| COVID-19 Vulnerability | 7 |
| Drinking Water | 0 |
| COVID-19 Hazard & Exposure | 4.7 |
| Population Living in Slums | n/a |
| Corruption Perception Index | 4.6 |
| Hospital Bed | 4.2 |
| Health System Capacity | 2.3 |
| Immunization Coverage | 1.45 |
| Health Capacity Specific to COVID-19 | 3.3 |
| COVID-19 Lack of Coping Capacity | 3.3 |
| Human Development Index | 0.89 |
| Incidence of Tuberculosis (per 10,000 people) | 11 |
| Malaria Incidence (per 1,000 people) | No data |
| Estimated Number of People Living With HIV (%) | 0.1 |
| Air Transport, Passengers Carried | 2,576,898 |
| Mobile Cellular Subscriptions (per 100 people) | 140.2 |
| Total Population | 440,377 |
| Land area (sq. km) | 320 |